Ledger.Open graph →
SEC Form D · Amendment · filed January 17, 2017

Thetis Pharmaceuticals LLC

Offering
$8.0M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SOUTHPORT, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Dennis M. Willson · Devon, PADirectorDavid M. Wurzer · Rocky Hill, CTDirectorGary F. Mathias · Southport, CTExec · DirectorFrank C. Sciavolino · Waterford, CTExec · DirectorWalter F. Ogier · Winchester, MADirectorBruce U. Carbonari · Horsham, PAExec · DirectorAlan Schnaid · Scottsdale, AZDirectorMitchell Ginsberg · Scottsdale, AZDirectorMarc Mirbod · Scottsdale, AZExec · DirectorGene H. Godick · Horsham, PAExec · DirectorNicholas U. Spring · Horsham, PADirectorDavid U. Jonas · Horsham, PADirectorTina H. Mcaleer · Horsham, PAExec · DirectorWalter F. Ogier · Winchester, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗